Cita APA (7a ed.)

Hill, R., Madureira, P. A., Ferreira, B., Baptista, I., Machado, S., Colaço, L., . . . Link, W. (2017). TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT. Nature Portfolio.

Cita Chicago Style (17a ed.)

Hill, Richard, et al. TRIB2 Confers Resistance to Anti-cancer Therapy by Activating the Serine/threonine Protein Kinase AKT. Nature Portfolio, 2017.

Cita MLA (8a ed.)

Hill, Richard, et al. TRIB2 Confers Resistance to Anti-cancer Therapy by Activating the Serine/threonine Protein Kinase AKT. Nature Portfolio, 2017.